Institute for Oncology and Radiology of Serbia; Medical Oncology

Belgrade 11000

0 studies enrolling now · 3 studies all time

What they study most

Bladder Cancer, Neoplasms, Non-Squamous Non-Small Cell Lung Cancer, Squamous Non-Small Cell Lung Cancer

Studies at this site

• A Study of Atezolizumab (MPDL3280A) Compared With a Platinum Agent (Cisplatin or Carboplatin) + (Pemetrexed or Gemcitabine) in Participants With Stage IV Non-Squamous or Squamous Non-Small Cell Lung Cancer (NSCLC) [IMpower110] — Completed
• An Extension (Rollover) Study of Vemurafenib in Participants With BRAF V600 Mutation-Positive Malignancies Previously Enrolled in an Antecedent Vemurafenib Protocol — Completed
• A Study of Atezolizumab Compared With Chemotherapy in Participants With Locally Advanced or Metastatic Urothelial Bladder Cancer [IMvigor211] — Completed